Back to search

Article

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.

2023-02-16

Abstract excerpt

<h4>Background: </h4> KMT2A -rearranged (KMT2A-R) is an aggressive and chemo-refractory acute leukemia which mostly affects children. Transcriptomics-based characterization and chemical interrogation identified kinases as key drivers of survival and drug resistance in KMT2A -R leukemia. In contrast, the contribution and regulation of phosphatases is unknown. We explored the role of SET, the endogenous inhibitor of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8e3d57b0-7add-5e4e-8f96-97bac2d54a40
DOI
10.21203/rs.3.rs-2583091/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.DOI 10.21203/rs.3.rs-2583091/v1
Select a neighboring publication to make it the new centre.